ArticleOncoimmunology

A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γ.

Hongtao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.